podophyllotoxin has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Long, L; Wang, J; Xu, Y; Zhang, L | 1 |
| Chen, X; Chen, Y; Liao, F; Liu, M; Wang, W; Wen, J; Wu, Q; Xu, D | 1 |
2 other study(ies) available for podophyllotoxin and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Down-Regulation; Drug Design; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Dynamics Simulation; Multidrug Resistance-Associated Proteins; Podophyllotoxin; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Signal Transduction; Tubulin | 2018 |
Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation.
Topics: Animals; Antigens, CD34; Apoptosis; Disease Models, Animal; Fetal Blood; Fusion Proteins, bcr-abl; Humans; In Vitro Techniques; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Transgenic; Microtubules; Neoplastic Stem Cells; Phosphorylation; Podophyllotoxin; Signal Transduction; Stem Cells; Transcriptional Activation; Tumor Suppressor Protein p53 | 2021 |